Details for Patent: 12,280,146
Which drugs does patent 12,280,146 protect, and when does it expire?
Patent 12,280,146 protects AMELUZ and is included in one NDA.
This patent has eight patent family members in seven countries.
Summary for Patent: 12,280,146
| Title: | Nanoemulsion without propylene glycol |
| Abstract: | The present invention relates to oil in water nanoemulsions which are essentially free of propylene glycol. The nanovesicle formulations are particularly stable in regard to shelf life at different storage temperatures. |
| Inventor(s): | Montserrat FOGUET, Lars MÖLLMANN |
| Assignee: | Biofrontera Inc |
| Application Number: | US18/533,497 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 12,280,146
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofrontera | AMELUZ | aminolevulinic acid hydrochloride | GEL;TOPICAL | 208081-001 | May 10, 2016 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,280,146
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2024253808 | ⤷ Start Trial | |||
| China | 120916750 | ⤷ Start Trial | |||
| Germany | 202024002778 | ⤷ Start Trial | |||
| European Patent Office | 4687833 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
